Clinical Trial Update: The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how prior pneumococcal vaccination affects immune response to Prevnar 13 in patients with severe chronic kidney disease. Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Lakehead University | Conditions: Chronic Kidney Diseases | Phase 4 | Status: COMPLETED